This Form 144 is a routine sell-to-cover transaction for RSU vesting, not a discretionary insider sale. The small share count relative to typical insider holdings suggests minimal market impact. Monitor for any subsequent Form 4 filings to confirm execution, but no material read-through for the stock.
Price Chart
Executive Summary
David Krempa, an officer of Eton Pharmaceuticals, filed a Form 144 on October 6, 2026, indicating intent to sell 4,166 shares of common stock, with an estimated aggregate market value of approximately $229,406. The sale is described as 'Sell to Cover for RSU vesting,' suggesting a routine transaction to cover tax withholding obligations upon vesting of restricted stock units, rather than a discretionary insider sale.
Key Facts
- Filer: David Krempa, an officer of Eton Pharmaceuticals
- Proposed sale of 4,166 shares of common stock
- Estimated aggregate market value: approximately $229,406
- Sale reason stated as 'Sell to Cover for RSU vesting'
- Shares acquired on 10/02/2026 via RSU vest from the issuer
- Filing date: October 6, 2026
Financial Impact
Proposed sale of 4,166 shares valued at ~$229,406, representing a routine sell-to-cover transaction for RSU vesting tax obligations
Risk Factors
- Insider may still execute the sale, though the stated purpose is tax withholding
- No material risk to the company's fundamentals from this filing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001974078-26-000377 |
| Document: 0001974078-26-000377-index.html | 0001974078-26-000377 |
| Document: 0001974078-26-000377.txt | 0001974078-26-000377 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $50.42 (−4.65%) |
Oct 6, 2026 20d ago | 144 | $54.88 | awaiting T+60 | — | $50.42 (−8.13%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $50.42 (−14.80%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $50.42 (−16.56%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $50.42 (−16.58%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $50.42 (+20.03%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $50.42 (+17.99%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $50.42 (+9.68%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $50.42 (+9.68%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $50.42 (+10.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers